Tacrolimus is widely used for the prevention of GVHD after allogeneic hematopoietic SCT(HSCT). 1, 2 Adverse events such as renal and hepatic toxicity have been associated with increased tacrolimus ...
ABBOTT PARK, Ill., Feb. 13, 2012 /PRNewswire/ -- A new study published in the journal Clinical Chemistry reported Abbott's (NYSE: ABT) ARCHITECT® Tacrolimus assay provides accurate and consistent ...
Thermo Scientific QMS Tacrolimus receives FDA 510(k) clearance. FREMONT, Calif.--(BUSINESS WIRE)--Transplant physicians working with clinical laboratories must carefully monitor and manage dosages of ...
Currently, monitoring of levels of the immunosuppressant tacrolimus requires repeated venous blood draws, which are costly, and inconvenient for patients and staff. Cheung et al. investigated whether ...
Tacrolimus and cyclosporine A show similar efficacy in long-term survival and relapse reduction in AML post-transplant patients. No significant differences were found in leukemia-free survival, ...
Tacrolimus 0.75mg, 1mg, 4mg; ext-rel tabs. Tacrolimus binds to an intracellular protein, FKBP-12. A complex of tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin (an ubiquitous mammalian ...
Tacrolimus and pimecrolimus are members of a new class of topical immunomodulators and belong to the class of immunosuppressant drugs known as calcineurin inhibitors. They work mainly by reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback